Home › Athersys, Inc. (ATHX) Upgraded to Buy at Zacks Investment Research
 

Keywords :   


Athersys, Inc. (ATHX) Upgraded to Buy at Zacks Investment Research

2016-03-12 01:37:03| Biotech - Topix.net

The brokerage presently has a $2.50 price target on the biopharmaceutical company's stock. Zacks Investment Research 's price objective would indicate a potential upside of 14.68% from the company's current price.

Tags: buy research investment upgraded

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Delayed implementation of EID eartag rule requested
More »